It has been documented that PDGFA/PDGFRA is highly expressed in GBM and plays critical roles in gliomagenesis, but targeting PDGFRA by small molecule inhibitors do not show therapeutic significance in clinic. The gene discussed is PDGFA; the disease is glioblastoma.